B/F/TAF
GS-US-380-4458
Phase 3 small_molecule completed
Quick answer
B/F/TAF for HIV-1/HBV Co-Infection is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- HIV-1/HBV Co-Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed